search
Back to results

Outcome Comparison of Two Total Knee Arthroplasty Systems: e.Motion-Pro Versus Genesis II

Primary Purpose

Osteoarthritis, Knee

Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
device: e.motion PS Pro
device : Genesis II
Sponsored by
Seoul National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee

Eligibility Criteria

undefined - 79 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients who are decided to undergo total knee arthroplasty with diagnosis of primary osteoarthritis

Exclusion Criteria:

  • the diagnosis other than primary osteoarthritis
  • previous history of infection or trauma requiring surgical treatment on the knee which will receive total knee arthroplasty
  • patients of 80 years or older
  • patients with systemic diseases that can affect functional outcomes of TKA

Sites / Locations

  • Joint Reconstruction Center, Seoul National University Bundang HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

e.motion PS Pro group

Genesis II group

Arm Description

the patients who receives total knee arthroplasty with the e.motion PS pro prosthesis

the patients who receives total knee arthroplasty with the Genesis II prosthesis

Outcomes

Primary Outcome Measures

prosthesis fit
Component fitness will be evaluated by whether there is overhang (too wide or big) or underhang (too narrow or small) more than 2 mm at any of three sites: condyle, junction, and anterior flange
pain level during gait at 3 months after surgery
Pain levels will be evaluated by asking how much pain patients feel during weight bearing gait at 3 months in 0-10 visual analog scale (0-no pain and 10-maximum pain)
knee swelling (circumference measured at the knee) at 3 months
Knee swelling will be evaluated by measuring the leg circumference at the knee level (mid-patella), and the measured circumference will be compared with the preoperative circumference
flexion contracture and maximum flexion at 3 months
Flexion contracture and further flexion will be measured by a single investigator using a 38-cm clinical goniometer with patients supine
the new American Knee Society (AKS) score at 6 months
Patients will be evaluated at 6 months using the new scoring system of American Knee Society. The American Knee Society scoring system evaluates multiple aspects of outcomes: 1) Objective knee indicators (maximum points 80) - alignment (25), mediolateral (ML) stability (15), anteroposterior (AP) stability (10), range of motion (ROM) (30); 2) Knee score (maximum points 80) - symptoms (25), patient satisfaction (40), and expectation (15); 3) Function score (maximum points 100) - walking & standing (30), standard activities (30), advanced activities (25), discretionary knee activities (15)

Secondary Outcome Measures

whether balanced gaps were achieved
Balanced gap achievement will be called when flexion-extension and medio-lateral gaps are not beyond 2 mm difference
tourniquet time
Tourniquet time will be measured as the duration in minutes from the point making skin incision to deflating tourniquet to check whether arterial bleeders are after implant fixation
blood volume drained via a vacuum drainage in the subcutaneous tissue
blood volume drained via a vacuum drainage will be measured as the total amount drained from the end of surgery to removal of vacuum drainage in mL.
hemoglobin drop on postoperative 2 and 5 days
hemoglobin drop on the 2nd and 5th postoperative days will be evaluated by subtracting hemoglobin level on the 2nd or 5th day from the preoperative level.
pain level during motion arc exercise at 2 and 6 weeks
Pain levels during motion arc exercise will be evaluated at 2 and 6 weeks using 0-10 Visual Analogue Scale.
knee swelling at 2 and 6 weeks
knee swelling will be evaluated at 2 and 6 weeks by noting the leg circumference at the mid-patella level
need for walking aid at 6 weeks
Whether patients still need a walking aid (yes/no) will be noted at 6 weeks
patient satisfaction with early recovery pattern at 3 months
Patient satisfaction with early recovery pattern will be evaluated at 3 month using a 0-4 Likert scales (0-disappointed, 1-less satisfactory than expected, 2 - as expected, 3- more satisfactory than expected, 4 - extremely satisfactory)
flexion contracture and further flexion at 6 weeks, and 6, 12, 24 months
Motion arc will be evaluated in extension deficit (flexion contracture) and maximum flexion at 6 weeks, 6 months, 12 months, and 2 years
patient satisfaction with replaced knees at 12 and 24 months
Patients will be evaluated for their satisfaction with replaced knees at 12 and 24 months after surgery with 0-4 Likert scale and 0-10 Visual analogue scale.

Full Information

First Posted
October 19, 2014
Last Updated
October 23, 2014
Sponsor
Seoul National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02276118
Brief Title
Outcome Comparison of Two Total Knee Arthroplasty Systems: e.Motion-Pro Versus Genesis II
Official Title
Comparisons of Prosthesis Fitness, Early Recovery Patterns, Functional Outcomes and Patient Satisfaction Between E.Motion-Pro, a New Mobile Bearing System and Genesis II, an Established Successful System
Study Type
Interventional

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Unknown status
Study Start Date
July 2014 (undefined)
Primary Completion Date
July 2015 (Anticipated)
Study Completion Date
December 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Seoul National University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Recently, E.Motion-PS-Pro (B.Braun-Aesculap, Tuttlingen, Germany), a new mobile bearing knee system with a unique ball and socket post-cam mechanism was developed for use in total knee arthroplasty. This study aims to determine (1) whether the use of E.Motion-PS-Pro improves prosthesis fitness for the femur and tibia in terms of under- or over-hang incidence compared to an established successful prosthesis, Genesis II (Smith & Nephew, Memphis, U.S.A.), (2) whether patients with this new prosthesis experience less pain and faster wound healing in early recovery phase, (3) whether patients with E.Motion-Pro reach functional plateaus faster than patients with Genesis II and the functional plateaus of patients with E.Motion-Pro are higher than those of patients with Genesis II.
Detailed Description
Total knee arthroplasty (TKA) is a satisfactory treatment option for patients with advanced knee diseases that are intractable with other modalities in terms of pain relief, functional restoration, and deformity correction. Unfortunately, however, many patients have to go through a recovery period of several months during which they experience considerable pain and suffer from incompletely restored functions. In recent years, to improve the quality of life during early recovery period after TKA, great efforts have been made in multiple areas including the use of minimally invasive surgical technique, improved pain management protocols, and postoperative rehabilitation protocols. Nonetheless, this almost inevitable presence of painful and disabling recovery period is a major concern to patients scheduled for or considering TKA as a treatment option. Furthermore, this issue can become a more serious obstacle to very elderly patients who have to balance the benefits of remaining years with improved functions from replaced knees and the burden of recovery duration after TKA. In theory, the use of a better fitting prosthesis with sound kinematic performance can shorten the duration of recovery period and improve the quality of life by reducing pain and facilitating functional recovery. Better fitting prostheses allegedly less involve prosthesis overhang at femoral condylar level, which can cause impingement symptoms and at anterior flange area, which can cause patellofemoral symptoms. Prosthesis providing better kinematic performance such as natural motion and joint stability throughout motion arc can reduce pain and discomfort in early recovery period and shorten the duration of recovery period. Recently, E.Motion-PS-Pro (B.Braun-Aesculap, Tuttlingen, Germany), a new mobile bearing knee system with a unique ball and socket post-cam mechanism was developed. This new prosthesis was designed to achieve better prosthesis fitting, to minimize bone loss from box preparations for post-cam mechanism, to improve joint stability throughout motion arc, particularly in high flexion, and to reduce the risk for wear and fracture at the post by increasing contact area. If the intended design rationales work out well, this prosthesis shall reduce soft tissue impingement and provide better kinematic performances, which reduces pain and facilitates functional restoration. Therefore, the current investigators aim to determine (1) whether the use of E.Motion-PS-Pro improves prosthesis fitness for the femur and tibia in terms of under- or over-hang incidence compared to an established successful prosthesis, Genesis II (Smith & Nephew, Memphis, U.S.A.), (2) whether patients with this new prosthesis experience less pain and faster wound healing in early recovery phase, (3) whether patients with E.Motion-Pro reach functional plateaus faster than patients with Genesis II and the functional plateaus of patients with E.Motion-Pro are higher than those of patients with Genesis II. The investigators hypothesize that (1) E.Motion-Pro reduces the incidence of prosthesis under- or over-hang, (2) patients with E.Motion-Pro experience less pain and faster wound healing in early recovery phase, and (3) patients with E.Motion-Pro reach functional plateau faster and the functional outcomes at 1 year are better in patients with E.Motion-Pro than those with Genesis II.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
e.motion PS Pro group
Arm Type
Experimental
Arm Description
the patients who receives total knee arthroplasty with the e.motion PS pro prosthesis
Arm Title
Genesis II group
Arm Type
Active Comparator
Arm Description
the patients who receives total knee arthroplasty with the Genesis II prosthesis
Intervention Type
Device
Intervention Name(s)
device: e.motion PS Pro
Intervention Description
patients will undergo total knee arthroplasty with e.motion PS Pro implant
Intervention Type
Device
Intervention Name(s)
device : Genesis II
Intervention Description
patients will undergo total knee arthroplasty with Genesis II implant
Primary Outcome Measure Information:
Title
prosthesis fit
Description
Component fitness will be evaluated by whether there is overhang (too wide or big) or underhang (too narrow or small) more than 2 mm at any of three sites: condyle, junction, and anterior flange
Time Frame
from the start to end of surgery (expected average of 90 minutes)
Title
pain level during gait at 3 months after surgery
Description
Pain levels will be evaluated by asking how much pain patients feel during weight bearing gait at 3 months in 0-10 visual analog scale (0-no pain and 10-maximum pain)
Time Frame
at 3 months after surgery
Title
knee swelling (circumference measured at the knee) at 3 months
Description
Knee swelling will be evaluated by measuring the leg circumference at the knee level (mid-patella), and the measured circumference will be compared with the preoperative circumference
Time Frame
at 3 months after surgery
Title
flexion contracture and maximum flexion at 3 months
Description
Flexion contracture and further flexion will be measured by a single investigator using a 38-cm clinical goniometer with patients supine
Time Frame
at 3 months after surgery
Title
the new American Knee Society (AKS) score at 6 months
Description
Patients will be evaluated at 6 months using the new scoring system of American Knee Society. The American Knee Society scoring system evaluates multiple aspects of outcomes: 1) Objective knee indicators (maximum points 80) - alignment (25), mediolateral (ML) stability (15), anteroposterior (AP) stability (10), range of motion (ROM) (30); 2) Knee score (maximum points 80) - symptoms (25), patient satisfaction (40), and expectation (15); 3) Function score (maximum points 100) - walking & standing (30), standard activities (30), advanced activities (25), discretionary knee activities (15)
Time Frame
at 6 months after surgery
Secondary Outcome Measure Information:
Title
whether balanced gaps were achieved
Description
Balanced gap achievement will be called when flexion-extension and medio-lateral gaps are not beyond 2 mm difference
Time Frame
from the start to end of surgery (expected average of 90 minutes)
Title
tourniquet time
Description
Tourniquet time will be measured as the duration in minutes from the point making skin incision to deflating tourniquet to check whether arterial bleeders are after implant fixation
Time Frame
from the start to end of surgery (expected average of 90 minutes)
Title
blood volume drained via a vacuum drainage in the subcutaneous tissue
Description
blood volume drained via a vacuum drainage will be measured as the total amount drained from the end of surgery to removal of vacuum drainage in mL.
Time Frame
from the end of surgery to removal of vacuum drainage (usually at 2 days after surgery)
Title
hemoglobin drop on postoperative 2 and 5 days
Description
hemoglobin drop on the 2nd and 5th postoperative days will be evaluated by subtracting hemoglobin level on the 2nd or 5th day from the preoperative level.
Time Frame
at 2 and 5 days after surgery
Title
pain level during motion arc exercise at 2 and 6 weeks
Description
Pain levels during motion arc exercise will be evaluated at 2 and 6 weeks using 0-10 Visual Analogue Scale.
Time Frame
at 2 and 6 weeks after surgery
Title
knee swelling at 2 and 6 weeks
Description
knee swelling will be evaluated at 2 and 6 weeks by noting the leg circumference at the mid-patella level
Time Frame
at 2 and 6 weeks after surgery
Title
need for walking aid at 6 weeks
Description
Whether patients still need a walking aid (yes/no) will be noted at 6 weeks
Time Frame
at 6 weeks after surgery
Title
patient satisfaction with early recovery pattern at 3 months
Description
Patient satisfaction with early recovery pattern will be evaluated at 3 month using a 0-4 Likert scales (0-disappointed, 1-less satisfactory than expected, 2 - as expected, 3- more satisfactory than expected, 4 - extremely satisfactory)
Time Frame
at 3months after surgery
Title
flexion contracture and further flexion at 6 weeks, and 6, 12, 24 months
Description
Motion arc will be evaluated in extension deficit (flexion contracture) and maximum flexion at 6 weeks, 6 months, 12 months, and 2 years
Time Frame
at 6 weeks, and 6, 12, 24 months after surgery
Title
patient satisfaction with replaced knees at 12 and 24 months
Description
Patients will be evaluated for their satisfaction with replaced knees at 12 and 24 months after surgery with 0-4 Likert scale and 0-10 Visual analogue scale.
Time Frame
at 12 and 24 months after surgery

10. Eligibility

Sex
All
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients who are decided to undergo total knee arthroplasty with diagnosis of primary osteoarthritis Exclusion Criteria: the diagnosis other than primary osteoarthritis previous history of infection or trauma requiring surgical treatment on the knee which will receive total knee arthroplasty patients of 80 years or older patients with systemic diseases that can affect functional outcomes of TKA
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tae Kyun Kim, MD, PhD
Phone
82-31-787-7196
Email
osktk@snubh.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tae Kyun Kim, MD, PhD
Organizational Affiliation
Seoul National University Bundang Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Joint Reconstruction Center, Seoul National University Bundang Hospital
City
Seongnam-si
State/Province
Gyeonggi-do
ZIP/Postal Code
463-707
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tae Kyun Kim, MD, PhD
Phone
82-31-787-7196
Email
osktk@snubh.org
First Name & Middle Initial & Last Name & Degree
Tae Kyun Kim, MD, PhD

12. IPD Sharing Statement

Learn more about this trial

Outcome Comparison of Two Total Knee Arthroplasty Systems: e.Motion-Pro Versus Genesis II

We'll reach out to this number within 24 hrs